Details of the Drug

General Information of Drug (ID: DMGLVBI)

Drug Name
JTT-302
Synonyms CETP inhibitor (oral, dyslipidemia), Japan Tobacco
Indication
Disease Entry ICD 11 Status REF
Lipid metabolism disorder 5C52.Z Phase 2 [1]
Cross-matching ID
TTD ID
D04ZBU

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cholesteryl ester transfer protein (CETP) TTFQAYR CETP_HUMAN Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Lipid metabolism disorder
ICD Disease Classification 5C52.Z
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Cholesteryl ester transfer protein (CETP) DTT CETP 8.86E-01 -0.1 -0.6
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 ClinicalTrials.gov (NCT00748852) Safety Study of JTT-302 in Subjects With Low HDL-C Levels. U.S. National Institutes of Health.
2 The dyslipidaemia market. Nat Rev Drug Discov. 2014 Nov;13(11):807-8.